小分子
结晶
蛋白质结晶
人类蛋白质
药物发现
化学
靶蛋白
生物化学
蛋白质稳定性
蛋白质结构
配体(生物化学)
计算生物学
激酶
生物
受体
有机化学
基因
作者
Masoud Vedadi,F. Niesen,Abdellah Allali‐Hassani,O. Fedorov,P.J. Finerty,Gregory A. Wasney,Ron Yeung,C.H. Arrowsmith,Linda Ball,H. Berglund,Raymond Hui,Brian D. Marsden,P. Nordlund,M. Sundström,Johan Weigelt,A.M. Edwards
标识
DOI:10.1073/pnas.0605224103
摘要
The 3D structures of human therapeutic targets are enabling for drug discovery. However, their purification and crystallization remain rate determining. In individual cases, ligands have been used to increase the success rate of protein purification and crystallization, but the broad applicability of this approach is unknown. We implemented two screening platforms, based on either fluorimetry or static light scattering, to measure the increase in protein thermal stability upon binding of a ligand without the need to monitor enzyme activity. In total, 221 different proteins from humans and human parasites were screened against one or both of two sorts of small-molecule libraries. The first library comprised different salts, pH conditions, and commonly found small molecules and was applicable to all proteins. The second comprised compounds specific for protein families of particular interest (e.g., protein kinases). In 20 cases, including nine unique human protein kinases, a small molecule was identified that stabilized the proteins and promoted structure determination. The methods are cost-effective, can be implemented in any laboratory, promise to increase the success rates of purifying and crystallizing human proteins significantly, and identify new ligands for these proteins.
科研通智能强力驱动
Strongly Powered by AbleSci AI